Figure 1.

Patient flow diagram. As of July 2016, 497 coinfected patients initiated hepatitis C virus (HCV) treatment, of whom 319 achieved sustained virologic response (SVR). Of these, 257 patients had at least 1 post-SVR HCV RNA measurement available and were included in the analysis. Patients excluded from the analysis (n = 62) were older (median age 52 years), more likely to be Aboriginal (15%), and less likely to be former (65%) or current (8%) injection drug users than those included. Abbreviations: HCV, hepatitis C virus; SVR, sustained virologic response.